APA (7th ed.) Citation

Decato, B. E., Yang, Z., Vengco, I., Paweletz, K., Pati, A., Reddy, A., . . . Smith, K. M. (2025). Abstract 727: Association of baseline tumor and peripheral biomarker features with efficacy in metastatic castration-resistant prostate cancer patients treated with xaluritamig. Cancer research (Chicago, Ill.), 85(8_Supplement_1), 727. https://doi.org/10.1158/1538-7445.AM2025-727

Chicago Style (17th ed.) Citation

Decato, Benjamin E., Zhao Yang, Isabelita Vengco, Katherine Paweletz, Amrita Pati, Anita Reddy, Tara O'Donohue, Sheryl Treichel, and Kristen M. Smith. "Abstract 727: Association of Baseline Tumor and Peripheral Biomarker Features with Efficacy in Metastatic Castration-resistant Prostate Cancer Patients Treated with Xaluritamig." Cancer Research (Chicago, Ill.) 85, no. 8_Supplement_1 (2025): 727. https://doi.org/10.1158/1538-7445.AM2025-727.

MLA (9th ed.) Citation

Decato, Benjamin E., et al. "Abstract 727: Association of Baseline Tumor and Peripheral Biomarker Features with Efficacy in Metastatic Castration-resistant Prostate Cancer Patients Treated with Xaluritamig." Cancer Research (Chicago, Ill.), vol. 85, no. 8_Supplement_1, 2025, p. 727, https://doi.org/10.1158/1538-7445.AM2025-727.